Efficacy of rituximab in the treatment of pulmonary rheumatoid nodules: Findings in 10 patients from the French AutoImmunity and Rituximab/Rheumatoid Arthritis registry (AIR/PR registry)

Annals of the Rheumatic Diseases

Volumn 71, Issue 8, 2012, Pages 1429-1431

  Glace, Baptiste ^a   Gottenberg, Jacques Eric ^b   Mariette, Xavier ^c   Philippe, Ravaud ^d   Pereira, Bruno ^a   Lequerré, Thierry ^e   Berthelot, Jean Marie ^f   Dougados, Maxime ^g   Toussirot, Eric ^h   Pham, Thao ⁱ   Allanore, Yannick ^g   Loeuille, Damien ^j   Euller Ziegler, Liana ^k   Soubrier, Martin ^a  

^a UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^b UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^c BICÊTRE HOSPITAL   (France)

^d BICHAT HOSPITAL   (France)

^e ROUEN UNIVERSITY HOSPITAL   (France)

^f UNIVERSITÉ DE NANTES   (France)

^g Institut Cochin   (France)

^h UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

ⁱ HÔPITAL DE LA CONCEPTION   (France)

^j UNIVERSITY HOSPITAL OF NANCY   (France)

^k UNIVERSITY HOSPITAL OF NICE   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; ETANERCEPT; LEFLUNOMIDE; METHOTREXATE; RITUXIMAB; SALAZOSULFAPYRIDINE; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ADULT; AGED; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ACTIVITY; DRUG EFFICACY; DRUG INFUSION; DRUG RESPONSE; FEMALE; HISTOPATHOLOGY; HUMAN; LETTER; LUNG NODULE; MALE; PRIORITY JOURNAL; PULMONARY RHEUMATOID NODULE; REGISTER; RHEUMATOID ARTHRITIS; SMOKING;

AGED; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; DRUG SUBSTITUTION; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; LUNG DISEASES; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PEPTIDES, CYCLIC; REGISTRIES; RHEUMATOID FACTOR; RHEUMATOID NODULE; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84863812341     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2011-200915     Document Type: Letter

References (10)

1. Lioté H. (Pulmonary manifestation of rheumatoid arthritis). Rev Mal Respir 2008;25:973-88.
2. Rozin A, Yigla M, Guralnik L, et al. Rheumatoid lung nodulosis and osteopathy associated with leflunomide therapy. Clin Rheumatol 2006;25:384-8.
3. Gotsman I, Goral A, Nusair S. Secondary spontaneous pneumothorax in a patient with pulmonary rheumatoid nodules during treatment with methotrexate. Rheumatology (Oxford) 2001;40:350-1. (Pubitemid 32266363)
4. Toussirot E, Berthelot JM, Pertuiset E, et al. Pulmonary nodulosis and aseptic granulomatous lung disease occurring in patients with rheumatoid arthritis receiving tumor necrosis factor-alpha-blocking agent: a case series. J Rheumatol 2009;36:2421-7.
5. Highton J, Hung N, Hessian P, et al. Pulmonary rheumatoid nodules demonstrating features usually associated with rheumatoid synovial membrane. Rheumatology (Oxford) 2007;46:811-14. (Pubitemid 47061714)
6. Gottenberg JE, Ravaud P, Bardin T, et al. Risk factors for severe infections in patients with rheumatoid arthritis treated with rituximab in the autoimmunity and rituximab registry. Arthritis Rheum 2010;62:2625-32.
7. Fautrel B, Pham T, Mouterde G, et al. Recommendations of the French Society for Rheumatology regarding TNFalpha antagonist therapy in patients with rheumatoid arthritis. Joint Bone Spine 2007;74:627-37. (Pubitemid 350236029)
8. De Stefano R, Frati E, Nargi F, et al. Efficacy of rituximab on pulmonary nodulosis occuring or increasing in patients with rheumatoid arthritis during anti-TNFα therapy. Ann Rheum Dis 2011;70(Suppl3):722.
9. Guignard S, Noel D, Aubart D, et al. Evolution favorable d'un poumon rhumatoïde sous rituximab: à propos d'un cas (abstract). Rev Rhum 2008;75:P1066.
10. Oqueka T, Schultz H, Moosig F. (Favorable response of pulmonary rheumatoid nodule to Rituximab). Z Rheumatol 2009;68:343-4.